| Issuer: | Eli Lilly and Company | |||||
| Size: | $1,000,000,000 | $1,000,000,000 | $400,000,000 | |||
| Maturity: | March 6, 2012 | March 6, 2014 | November 15, 2037 | |||
| Coupon: | 3.550% per year | 4.200% per year | 5.950% per year | |||
| Price: | 99.898% of principal amount | 99.955% of principal amount | 99.019% of principal amount | |||
| Yield to maturity: | 3.586% | 4.210% | 6.023% | |||
| Spread to Benchmark Treasury: | 2.300% | 2.375% | 2.400% | |||
| Benchmark Treasury: | 1.375% due 02/15/2012 | 1.875% due 02/28/2014 | 4.500% due 05/15/2038 | |||
| Benchmark Treasury Price and Yield: | 100-081/4 1.286% | 100-06 1.835% | 115-23 3.623% | |||
| Interest Payment Dates: | March 6 and September 6, commencing September 6, 2009 | March 6 and September 6, commencing September 6, 2009 | May 15 and November 15, commencing May 15, 2009 | |||
| Redemption Provisions: | ||||||
| Make-whole call | Make-whole plus 35 bps | Make-whole plus 35 bps | Make-whole plus 35 bps | |||
| CUSIP: | 532457 BD9 | 532457 BE7 | 532457 BC1 | |||
| Settlement: | T+3 (March 6, 2009) | |||||
| Ratings: | Moody’s: A1 (stable) Standard & Poor’s: AA (stable) | |||||
| Denominations: | $2,000 x $1,000 | |||||
| Joint Book-Running Managers: | Credit Suisse Securities (USA) LLC, Deutsche Bank Securities Inc., UBS Securities LLC, Banc of America Securities LLC, Citigroup Global Markets Inc. | |||||
